Companies: 10,795·Total market cap: $144.5T
Genenta Science S.p.A.

Genenta Science S.p.A.

GNTANASDAQHealthcare● Active
$1.80
+$0.00(+0.13%)
Market Cap$34507679
P/E Ratio—
52W High$10
52W Low$0.55
Overview
Foreign Private Issuer · Files 20-F / 6-K

Genenta Science S.p.A. (GNTA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001838716 · GNTA · NASDAQ · as of Jun 10, 2026

Filing snapshot

104
Total Filings
6-K
Latest Form
2026-05-29
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001838716 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-01
Fiscal Year End
Apr 1, 2026
Accession No.
0001493152-26-014387
Primary Document
form20-f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001838716 · Accession 0001493152-26-014387

Latest Key Filings

6-KQuarterly Report
6-K
2026-05-29
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-29
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-19
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-05-05
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-28
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-23
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-14
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-27
View
3Initial Statement of Beneficial Ownership
3
2026-03-25
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-24
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
3Initial Statement of Beneficial Ownership
3
2026-03-18
View
Showing 1–15 of 98 filingsForm 4 / 144 hidden· 104 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001838716  |  Exchange: NASDAQ · Healthcare

Genenta Science S.p.A. (NASDAQ: GNTA) has submitted 104 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001838716, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Genenta Science S.p.A.'s most comprehensive regulatory disclosure. The most recent Genenta Science S.p.A. 10-K was filed on 2026-04-01 for fiscal year ending 2026. Historical GNTA 10-K annual reports are available from 2021 through 2026.

Investors researching Genenta Science S.p.A. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
IPSC SEC Filings →MRSN SEC Filings →TELO SEC Filings →INMB SEC Filings →BRNS SEC Filings →SKYE SEC Filings →SER SEC Filings →CVM SEC Filings →
→ GNTA Financials→ GNTA Earnings→ GNTA Insider Trades

Frequently Asked Questions

GNTA SEC Filings · 8 questions

Genenta Science S.p.A. (GNTA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 104 filings and access original documents at no cost. Genenta Science S.p.A.'s CIK is 0001838716.

GNTA SEC filingsGenenta Science S.p.A. SEC documentsfind GNTA 10-K